Details for New Drug Application (NDA): 088147
✉ Email this page to a colleague
NDA 088147 describes AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%, which is a drug marketed by Hospira and is included in two NDAs. Additional details are available on the AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% profile page.
The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
Summary for 088147
| Tradename: | AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% |
| Applicant: | Hospira |
| Ingredient: | aminophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088147
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/100ML | ||||
| Approval Date: | May 3, 1983 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | May 3, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
